Exhaled nitric oxide is not a biomarker for idiopathic pulmonary arterial hypertension or for treatment efficacy

被引：0
|
作者：
Majid Malekmohammad
Gert Folkerts
Babak Sharif Kashani
Parisa Adimi Naghan
Zahra Habibi Dastenae
Batoul Khoundabi
Johan Garssen
Esmaeil Mortaz
Ian M. Adcock
机构：
[1] Tracheal Disease Research Center,Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science
[2] National Research Institute of Tuberculosis and Lung Diseases (NRITLD),undefined
[3] Shahid Beheshti University of Medical Sciences,undefined
[4] Utrecht University,undefined
[5] Chronic Respiratory Diseases Research Center,undefined
[6] National Research Institute of Tuberculosis and Lung Diseases (NRITLD),undefined
[7] Shahid Beheshti University of Medical Sciences,undefined
[8] Helal-e-Iran Applied Science Higher Education Institute Red crescents society of Iran,undefined
[9] Clinical Tuberculosis and Epidemiology Research Center,undefined
[10] National Research Institute of Tuberculosis and Lung Diseases (NRITLD),undefined
[11] Shahid Beheshti University of Medical Sciences,undefined
[12] Cell and Molecular Biology Group,undefined
[13] Airways Disease Section,undefined
[14] Faculty of Medicine,undefined
[15] National Heart and Lung Institute,undefined
[16] Imperial College London,undefined
[17] Priority Research Centre for Asthma and Respiratory Disease,undefined
[18] Hunter Medical Research Institute,undefined
[19] University of Newcastle,undefined
来源：
BMC Pulmonary Medicine | / 19卷
关键词：
FeNO; Hypertention; Lungs; Exhaled nitric oxide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Therapy for Pulmonary Arterial Hypertension: Glance on Nitric Oxide Pathway
    Tettey, Abraham
    Jiang, Yujie
    Li, Xiaohui
    Li, Ying
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [42] Erythrocyte Derived Nitric Oxide Production in Pulmonary Arterial Hypertension
    Ulker, Pinar
    Ozen, Nur
    Basarici, Ibrahim
    Kilavuz, Ece
    Basrali, Filiz
    Koksoy, Sadi
    ACTA PHYSIOLOGICA, 2019, 227 : 27 - 27
  • [43] Nitric Oxide Deficiency and Endothelial Dysfunction in Pulmonary Arterial Hypertension
    Klinger, James R.
    Abman, Steven H.
    Gladwin, Mark T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (06) : 639 - 646
  • [44] Use of Exhaled Nitric Oxide as a Biomarker in Diagnosis and Management of Chronic Obstructive Pulmonary Disease
    Arif, Ahmed A.
    Mitchell, Colin
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2016, 7 (02): : 102 - 106
  • [45] Idiopathic pulmonary arterial hypertension
    Firth, Amy L.
    Mandel, Jess
    Yuan, Jason X. -J.
    DISEASE MODELS & MECHANISMS, 2010, 3 (5-6) : 268 - 273
  • [46] Idiopathic Pulmonary Arterial Hypertension
    Souza, Rogerio
    Jardim, Carlos
    Humbert, Marc
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (05) : 560 - 567
  • [47] Idiopathic Pulmonary Arterial Hypertension?
    Rigney, K.
    O'Brien, E.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2020, 189 (SUPPL 4) : 69 - 70
  • [48] Scleroderma pulmonary arterial hypertension: the same as idiopathic pulmonary arterial hypertension?
    Khan, Sarah L.
    Mathai, Stephen C.
    CURRENT OPINION IN PULMONARY MEDICINE, 2023, 29 (05) : 380 - 390
  • [49] Exhaled nitric oxide as a clinical biomarker for choosing biologics for severe asthma treatment
    Fuschillo, Salvatore
    Heffler, Enrico
    Maniscalco, Mauro
    BIOMARKERS IN MEDICINE, 2020, 14 (07) : 499 - 502
  • [50] The Ratio Of Pulmonary Artery Over Wedge Nitrite Predicts The Pulmonary Vascular Response To Inhaled Nitric Oxide In Idiopathic Pulmonary Arterial Hypertension
    Tonelli, A. R.
    Ahmed, M. K.
    Dakkak, W.
    Aulak, K.
    Dweik, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
12345